1,000
Participants
Start Date
October 28, 2025
Primary Completion Date
December 31, 2029
Study Completion Date
December 31, 2029
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda
National Institute of Allergy and Infectious Diseases (NIAID)
NIH